Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

ACAT inhibitors described by Sankyo in patent literature

Nov. 13, 1997

Palatin obtains rights to new ED diagnostic/therapeutic

Nov. 12, 1997

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears new indication for Zocor

Nov. 11, 1997

Orphan Medical receives approvable letter from FDA for Sucraid

Nov. 11, 1997

PPAR-gamma agonists for endocrine and metabolic disorders

Nov. 11, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Cerebrus uses studies on Redux to design new antiobesity agents

Nov. 10, 1997

Profile of Green Cross's rHSA

Nov. 7, 1997

Cell Genesys reports delivery of erythropoietin gene therapy

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...